New Drugs in Lung Cancer Chemotherapy

New targets and drugs in cancer chemotherapy.

Cancer is still the number two cause of death in highly developed countries. Due to increased life expectancy, the number of cancer cases has also increased, and it is not likely that the incidence of this often fatal illness will decrease in the near future. Breast cancer, for instance, strikes 1 of 8 women in the industrialized world. Incidence of lung cancer increases due to smoking, while t...

Chemotherapy and New Drugs in Prostate Cancer

Prostate cancer (PrC) is the fourth most common cancer (for both sexes combined) and the second most common cancer in men (accounting for 15% of all new male cancer cases), with a worldwide incidence of approximately 1,111,200, a 5-year prevalence of 3,924,000, and a mortality incidence of 307,000 for the year 2012.1 Since the 1990s, the increasing use of prostate-specific antigen (PSA) testing...

New perspectives in lung cancer.5. New drugs in lung cancer.

Factors influencing hematologists-oncologists’ prescription of chemotherapy drugs in cancer treatment in Iran: aninterview-questionnaire study

Cancer can be treated by surgery, chemotherapy, radiation therapy, hormonal therapy, and targeted therapy. The choice of treatment dependson the type and stage of the cancer. Chemotherapy drugs play an important role in cancer treatment. The objective of this interview-questionnaire study is to explore what influences Iranian hematologists-oncologists’ prescription when prescribing chemotherapy...

P-197: Study about Relation between Cancer, Chemotherapy and Chemical Drugs in Woman Infertility

Background: Female infertility varies widely by geographic location around the world. In 2010, there was an estimated 48.5 million infertile couples worldwide, and from 1990 to 2010 there was slight change in levels of infertility in most of the world. In 2010, the countries with the lowest rates of female infertility included the South American countries of Peru, Bolivia, Ecuador and Bolivia, ...